265 filings
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
3 May 24
Entry into a Material Definitive Agreement
8:00am
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
11 Mar 24
Regulation FD Disclosure
7:30am
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
6 Mar 24
Other Events
4:20pm
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
14 Feb 24
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
7:35am
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
1 Feb 24
Other Events
4:20pm
8-K
t9s ovifl
29 Jan 24
Other Events
4:15pm
8-K
i2y7 uqj2jh7
27 Dec 23
Departure of Directors or Certain Officers
4:56pm
8-K
cryhos8 3dbm
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
iyq2j
14 Dec 23
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
5:03pm
8-K
516lsp
19 Sep 23
Other Events
8:30am
8-K
o6ak7iqnl9bhvto
1 Sep 23
Material Modifications to Rights of Security Holders
8:30am
8-K
cdv9qy wbjdfwqwkf
31 Aug 23
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
5:18pm
8-K
z33vt2rea3y
22 Aug 23
Other Events
8:30am
8-K
ncj f0co83z3hohn
14 Aug 23
Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
8:15am
8-K
pucsrt0
20 Jul 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7:31pm
8-K
3mnxjp zuhujya
30 Jun 23
Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
8:59am
8-K
elq08x6rjsz
10 May 23
Sonnet BioTherapeutics Provides Fiscal Year 2023 Second Quarter and Year-to-Date Business and Earnings Update
7:30am
8-K
08tb56r21 ft
18 Apr 23
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 at the 2023 American Association for Cancer Research (AACR) Annual Meeting
5:00pm
8-K
n9ercr ngzk
24 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
l7fuh
10 Mar 23
Regulation FD Disclosure
4:24pm